SUMMARY We report the cases of two renal transplant recipients suffering from idiopathic portal hypertension, a condition characterised by increased portal venous pressure in the absence of both histological lesion of the liver and obstruction of the portal vein. In these two patients, perisinusoidal fibrosis, invisible by light microscopy, was demonstrated by electron microscopy; it is suggested that partial obstruction of hepatic sinusoids by perisinusoidal fibrosis could be the mechanism for increased portal venous pressure in all the patients with idiopathic portal hypertension. In these two patients, who received 6-mercaptopurine and azathioprine, perisinusoidal fibrosis might be the consequence of prolonged administration of these drugs.
Idiopathic portal hypertension is a condition characterised by increased portal venous pressure in the absence of both histological lesion of the liver and obstruction of the portal vein. The purposes of this paper are (1) to point out that idiopathic portal hypertension can develop in renal transplant recipients, (2) to show that the increase in portal venous pressure results from perisinusoidal fibrosis, invisible by light microscopy and demonstrable only by electron microscopy, and (3) to offer the hypothesis that perisinusoidal fibrosis might be the consequence of prolonged administration of 6-mercaptopurine and azathioprine or of immune reactions related to renal transplantation. (Fig. 1) ; electron microscopy demonstrated fibrosis within all the spaces of Disse which were examined (Fig. 2) In December 1975 end-to-side portaval shunt was performed. Light microscopy of a liver specimen taken at surgery showed normal liver histology (Fig. 4) ; electron microscopy demonstrated fibrosis within almost all the spaces of Disse which were examined (Fig. 5) . From December 1975 to December 1977, no further episode of gastrointestinal bleeding occurred.
Discussion
Idiopathic portal hypertension is defined by the association of (1) increased portal venous pressure, (2) patent portal vein, and (3) histologically normal liver. Cases meeting these criteria have been reported under various designations: essential portal hypertension (Benhamou et al., 1962) , sinusoidal portal hypertension (Kluge et al., 1970) , intermittent portal hypertension (Mendenhall et al., 1974) , non- Fig. 3 Case 1. Liver specimen taken four months after the specimen shown in Fig. 1 cirrhotic portal hypertension (Morris et al., 1974) , non-cirrhotic portal fibrosis (Sama et al., 1971) , portal hypertension in the presence of normal liver morphology (Iber, 1970) , portal hypertension in the absence of both liver disease and vascular obstruction (Miller and Brandt, 1962) . The prevalence of idiopathic portal hypertension seems to be low in Europe (Lortat-Jacob et al., 1967; Kluge et al., 1970; Morris et al., 1974) and North America (Tisdale et al., 1959; Mikkelsen et al., 1965; Boyer et al., 1974; Villeneuve et al., 1976) , but much higher in India (Boyer et al., 1967; Sama et al., 1971) and Japan (Imanaga et al., 1962) .
The main clinical manifestations of idiopathic portal hypertension are splenomegaly and bleeding oesophageal varices. Ascites is uncommon and, when present, is moderate and transient (Boyer et al., 1967; Kluge et al., 1970; Sama et al., 1971) . Hepatic encephalopathy, jaundice, and spiders are absent. Liver function tests are usually normal, except for BSP elimination.
The mechanism for increased portal venous pressure in idiopathic portal hypertension is controversial. It has been suggested that portal hypertension could result from the effect of vasoactive substances on the intrahepatic portal venous network (Iber, 1969; Mendenhall et al., 1974) ; the nature, the source and even the existence of these vasoactive substances are, in fact, entirely conjectural; moreover, the paucity of the smooth muscular component in the wall of the intrahepatic branches of the portal vein (Rappaport, 1975) makes vasoconstriction an unlikely mechanism for portal hypertension. It has been hypothesised that idiopathic portal hypertension could be the consequence of thrombosis of intrahepatic portal venules; this hypothesis is based on angiography showing interruption of these vessels (Villeneuve et al., 1976) ; however, in most patients with idiopathic portal hypertension, obstruction of the intrahepatic venules has not been histologically demonstrated, even in large liver specimens such as those obtained from our patients; nevertheless, thrombosis of the intrahepatic portal venules has been found at necropsy in a certain number of patients with idiopathic portal hypertension ; we suggest that the absence of obstruction of the intrahepatic portal venules in the liver specimens taken by biopsy and their presence at necropsy might be explained by thrombosis being a complication of the end stage, and not the cause of, idiopathic portal hypertension.
We propose the hypothesis that idiopathic portal hypertension could be due to partial obstruction of hepatic sinusoids by perisinusoidal fibrosis, invisible by light microscopy and demonstrable only by electron microscopy. This hypothesis is consistent with, and is reinforced by, the following observations: (1) perisinusoidal fibrosis has been demonstrated in our two patients as well as all the reported cases in which electron microscopic examination has been performed (Kluge et al., 1970; Tandon et al., 1970; Sama et al., 1971) ; (2) increase in wedged hepatic venous pressure, observed in our two patients and in some reported cases (Boyer et al., 1967; Iber, 1970; Sama et al., 1971; Mendenhall et al., 1974; Villeneuve et al., 1976) , may be reasonably ascribed to perisinusoidal fibrosis and would be hardly compatible with obstruction of the intrahepatic portal venules; (3) in our patient 1, perisinusoidal fibrosis, initially demonstrable only by electron microscopy, was followed by more marked fibrosis, then visible by light microscopy. It is conceivable that perisinusoidal fibrosis and hepatoportal sclerosis (Mikkelsen et al., 1965) may represent the early and the late stage of a unique entity; this concept offers an explanation for the existence of intermediates between these two liver lesions and for the parallelism in the geographic distribution of idiopathic portal fibrosis and hepatoportal sclerosis (Imanaga et al., 1962; Boyer et al., 1967; Iber, 1970; Sama et al., 1971) .
Decrease in BSP clearance, a disorder which was present in our patient 1 and in several reported cases (Tisdale et al., 1959; Iber, 1970; Sama et al., 1971; Morris et al., 1974; Villeneuve et al., 1976) , could be ascribed to perisinusoidal fibrosis impeding the transfer of the dye from blood to hepatocytes across the spaces of Disse. The other possible mechanisms for the decreased BSP clearancenamely, hepatocytic dysfunction and reduced liver blood flow-are unlikely, as the hepatocytes are morphologically normal and liver blood flow has been found to be not or only slightly diminished (Benhamou et al., 1962; Iber, 1970; Huet et al., 1975; Villeneuve et al., 1976) in idiopathic portal hypertension.
The cause of perisinusoidal fibrosis in our patient is uncertain. The fortuitous coincidence of renal transplantation and perisinusoidal fibrosis cannot be ruled out, but is unlikely, as renal transplantation and idiopathic portal hypertension are very uncommon conditions in the general population in France. In a small number of patients with idiopathic portal hypertension or hepatoportal sclerosis, the liver lesion has been attributed to prolonged administration of arsenic (Morris et al., 1974; Huet et al., 1975) or methotrexate (Talerman and Thompson, 1966; Podurgiel et al., 1973) , hypervitaminosis A (Russell et al., 1974) , inhalation of vinyl chloride (Thomas et al., 1975; Smith et al., 1976) ; none of these factors was implicated in our patients. Hepatic fibrosis has been reported in a few patients receiving 6-mercaptopurine (Lascari et al., 1968) or azathioprine (Zarday et al., 1972; Du Vivier et al., 1974; Freiberger et al., 1974) , two chemically related compounds which were administered to our patients; if, according to our hypothesis, perisinusoidal fibrosis and hepatoportal sclerosis are two stages of a unique entity, these reports strongly suggest that 6-mercaptopurine and azathioprine might be the cause of the liver lesion and portal hypertension in our patients. The role of renal transplantation itself in the determination of perisinusoidal fibrosis, although conjectural, cannot be excluded. It may be relevant to mention that, in schistosomiasis Mansoni with specific lesions confined to the portal tracts, non-specific perisinusoidal fibrosis affecting the whole length of the sinusoids has been demonstrated and attributed to deposition of complexes of antibody and antigen produced by the parasites (Grimaud and Borojevic, 1977) ; similarly, perisinusoidal fibrosis after renal transplantation might result from deposition of immune complexes the presence of which is common in these patients (Palusuo et al., 1976) . 
